Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of PTSD (PTSD) in Military Veterans
This study evaluates the safety and effectiveness of Psilocybin for people with PTSD.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of Psilocybin for people with PTSD.
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- LeatherheadSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 8
- Sponsor
- Combat Stress
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05876481
- Official title
Show the full official title
Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans
Recruitment & locations
Leatherhead
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of Psilocybin for people with PTSD.
Who is behind this study?
The study sponsor is Combat Stress.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
